Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review
Abstract There is increasing evidence that cannabidiol (CBD) use is associated with clinically significant liver enzyme (LE) elevations and drug‐induced…
Lindsay A. Lo
Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)
Abstract Cannabidiol (CBD) is widely used and believed to be non-intoxicating, lacking acute performance effects (e.g., non-impairing). However, a synthesis…
Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review
Abstract Objective: The drug poisoning crisis throughout North America necessitates novel harm reduction approaches. Emerging evidence suggests that cannabidiol (CBD)…
A Clinical Framework for Evaluating Cannabis Product Quality and Safety
Abstract Increase in medical cannabis use, along with available products, warrants the need for clinicians to be knowledgeable in evaluating…
Factors Associated with Problematic Cannabis Use in a Sample of Medical Cannabis Dispensary Users
Abstract Background: With the recent legalization of cannabis for medical purposes in many countries, there has been an increased number…
A Clinical Framework for Assessing Cannabis-Related Impairment Risk
Abstract Clinicians play an important role in promoting safe and responsible medical cannabis use. One essential component to safe use…
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
Abstract While the recreational use of cannabis has well-established dose-dependent effects on neurocognitive and psychomotor functioning, there is little consensus…